SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-021451
Filing Date
2022-03-29
Accepted
2022-03-29 16:09:39
Documents
2
Period of Report
2022-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1510
2 POA DOCUMENT poa.txt EX-24 4275
  Complete submission text file 0001209191-22-021451.txt   7192
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Issuer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ADVERUM BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address
Thedinga Angela (Reporting) CIK: 0001804588 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39370 | Film No.: 22780871